Publications by authors named "N Rieser"

This chapter offers a comprehensive overview of our current understanding of the neural mechanisms underlying the effects of psychedelic drugs, with a primary focus on human neuroimaging studies. Whenever possible, we explore the neurobiological mechanisms that may underly acute and subacute adverse effects and describe hypotheses on how these results may inform on the pathophysiology of psychiatric illnesses. We delve into the general effects of psychedelics on EEG, fMRI, and PET measurements, drawing insights from experiments that have assessed their acute biological mechanisms.

View Article and Find Full Text PDF

In the central nervous system of vertebrates, glutamate serves as the primary excitatory neurotransmitter. However, in the retina, glutamate released from photoreceptors causes hyperpolarization in post-synaptic ON-bipolar cells through a glutamate-gated chloride current, which seems paradoxical. Our research reveals that this current is modulated by two excitatory glutamate transporters, EAAT5b and EAAT7.

View Article and Find Full Text PDF

Background: Ketamine has emerged as one of the most promising therapies for treatment-resistant depression. However, inter-individual variability in response to ketamine is still not well understood and it is unclear how ketamine's molecular mechanisms connect to its neural and behavioral effects.

Methods: We conducted a single-blind placebo-controlled study, with participants blinded to their treatment condition.

View Article and Find Full Text PDF

Background: Today, online communication is shaped by a billion-dollar social media (SM) and social networking site (SNS) industry. Visual content consumed by children and adolescents has been shown to influence behavioral patterns, state emotions, and self-esteem (SE). In this study, we introduced a novel intervention creating visual content through a professional photoshoot and investigated its impact on state emotions and SE in child and adolescent psychiatric (CAP) patients.

View Article and Find Full Text PDF
Article Synopsis
  • Research on psilocybin for treating psychiatric disorders is expanding, but the connection between brain changes and subjective experiences is not well established.
  • A study involving 70 healthy participants examined how different doses of psilocybin affect cerebral blood flow (CBF) and how individual characteristics relate to these effects.
  • Results indicated that personal baseline characteristics influenced the brain's response to psilocybin, linking subjective experiences to measurable brain changes and suggesting potential for personalized treatment strategies in psychedelic therapy.
View Article and Find Full Text PDF